<DOC>
	<DOCNO>NCT00131118</DOCNO>
	<brief_summary>This extension study examine long-term safety efficacy zoledronic acid patient complete core CZOL446H2202 study .</brief_summary>
	<brief_title>Zoledronic Acid Children ( 1 -17 Years ) With Severe Osteogenesis Imperfecta</brief_title>
	<detailed_description />
	<mesh_term>Osteogenesis Imperfecta</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Have complete core CZOL446H2202 study Males females 117 year age Deformity abnormality would prevent spine bone density do Any surgical bonelengthening procedure Any kidney disease abnormality Low calcium vitamin D level blood Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Osteogenesis Imperfecta , Brittle bone disease , bisphosphonate , child</keyword>
</DOC>